NCT00864903

Brief Summary

A new enzymatic assay was developed by NMD Diagnostics for rapid diagnosis of Enteroviral CNS infection. This study will compare this assay to RT-PCR, by testing human CSF samples taken from children at the ER who are undergoing a spinal tap due to suspicion of meningitis.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Apr 2009

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 18, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 19, 2009

Completed
13 days until next milestone

Study Start

First participant enrolled

April 1, 2009

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2009

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2009

Completed
Last Updated

May 16, 2017

Status Verified

March 1, 2009

Enrollment Period

6 months

First QC Date

March 18, 2009

Last Update Submit

May 14, 2017

Conditions

Keywords

enterovirusaseptic meningitisreal time PCRdiagnostics

Study Arms (1)

pediatric ER

any child undergoing a spinal tap due to suspected meningitis

Eligibility Criteria

AgeUp to 16 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

children age 0-16 years who undergo a spinal tap at the pediatric ER due to suspected meningitis.

You may qualify if:

  • any child undergoing a spinal tap
  • parents agreed on participation

You may not qualify if:

  • refusal to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Shaare Zedek Medical Center

Jerusalem, 91031, Israel

Location

MND Diagnostics

Ness Ziona, 74036, Israel

Location

Biospecimen

Retention: SAMPLES WITH DNA

Cerebrospinal Fluid

MeSH Terms

Conditions

Meningitis, ViralEnterovirus InfectionsMeningitis, Aseptic

Condition Hierarchy (Ancestors)

Central Nervous System Viral DiseasesCentral Nervous System InfectionsInfectionsVirus DiseasesCentral Nervous System DiseasesNervous System DiseasesMeningitisNeuroinflammatory DiseasesPicornaviridae InfectionsRNA Virus Infections

Study Officials

  • Yechiel Schlesinger, MD

    Shaare Zedek Medical Center

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

March 18, 2009

First Posted

March 19, 2009

Study Start

April 1, 2009

Primary Completion

October 1, 2009

Study Completion

November 1, 2009

Last Updated

May 16, 2017

Record last verified: 2009-03

Locations